Worldwide Needle Free Diabetes Administration Business to 2029 – by Machine Sort and Geography – ResearchAndMarkets.com |

0
357

DUBLIN – (BUSINESS WIRE) – April 29, 2021–

This report, titled “Needle-Free Diabetes Management,” examines different types of devices such as treatment devices, diagnostic devices, and artificial pancreas, each of which is divided. According to the International Diabetes Federation, one in 11 adults will have diabetes in 2015 and one in ten adults is expected to have diabetes by 2040. The data suggest that one person dies of diabetes every 6 seconds in 2015. Therefore, diabetes management is one of the most important aspects to prevent the life-threatening effects of this disease. The ongoing research and development activities in the field of diagnosis and treatment of diabetes are expected to change the aspect of the market in the coming years.

For the purposes of this study, the worldwide Needle-Free Diabetes Management Market is divided into Treatment Devices, Diagnostic Devices, and Artificial Pancreas on the basis of device type. Treatment devices include insulin pens, pumps and patches, inhalers and jet injectors. Diagnostic devices are further subdivided into CGM devices (Continuous Glucose Monitoring) and FGM systems (Flash Glucose Monitoring). Market size estimates and forecasts for these segments for the period 2019 to 2029 are given in USD Mn along with the respective compound annual growth rates (CAGRs) for the period 2021 to 2029, taking 2020 as the base year.

The Needle-Free Diabetes Management market has been geographically segmented into key regions such as North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa. Each geographic market is further split to provide market revenue for select countries such as the US, Canada, UK, Germany, China, Japan, Brazil and the GCC countries. The market size and forecast for these segments in the years 2019 to 2029 as well as their CAGR for the period 2021 to 2029 are contained in this report.

  • Zogenix Inc.
  • 3M
  • Antares Pharma Inc.
  • Glide Pharmaceutical Technologies Ltd.
  • Injex Pharma AG
  • Pharmajet Inc.
  • Bioject Medical Technologies Inc.
  • Medtronic Inc.
  • Johnson & Johnson Inc.
  • Pancreum LLC
  • Tandem Diabetes Care Inc.
  • JDRF
  • Accra Dermojet

Chapter 2 Summary

2.1 Global Needle-Free Diabetes Management Market, By Device Type, 2020 v / s 2029 (Value%)

2.2 Global Needle-Free Diabetes Management Market by Geography, 2020 (Value%)

Chapter 3 Global Needle-Free Diabetes Management Market Review

3.2.1 Increase in the prevalence of diabetes due to increasing obesity and sedentary lifestyle in people

3.2.2 Growing development and success of continuous glucose monitors

3.3.1 Creating a Fast-Acting Insulin and Glucagon Formula

3.3.2 Regulatory hurdles and cost restrictions

3.4.1 Development of next generation glucose sensors

3.4.2 Intensive investment in R&D efforts

3.5 Attractive investment offer

3.6 Assessment of market competition: needle-free diabetes management by major players

3.6.1 Needle-Free Diabetes Management Market, Key Players Analysis by Treatment Devices

3.6.2 Needle-Free Diabetes Management Market, Key Players Analysis by Diagnostic Devices

Chapter 4 Global Needle-Free Diabetes Management Market Analysis, By Device Type

4.2.1 Insulin jet injector

4.2.4 Insulin Patch & Pump

4.3.1 Continuous Glucose Monitoring System (CGM)

4.3.2 Flash Glucose Monitoring (FGM) System

4.4 Devices and systems for artificial pancreas

Chapter 5 Global Diabetes Management Needle-Free Transplant Market By Geography

5.4.3 Rest of Asia Pacific

5.5.3 Rest of Latin America

5.6 Middle East and Africa

Chapter 6 Company Profiles

Laura Wood, Senior Press Manager

For EST office hours, call 1-917-300-0470

For US / CAN Toll Free, call 1-800-526-8630

For GMT office hours, call + 353-1-416-8900

KEYWORD IN INDUSTRY: HEALTH DIAGNOSIS

SOURCE: Research and Markets

Copyright Business Wire 2021.

PUB: 04/29/2021 8:56 AM / DISC: 04/29/2021 8:56 AM

Copyright Business Wire 2021.